# To Investigate Safety, Tolerability and Pharmacokinetics of TC-5214 in Healthy Male Japanese Subjects

> **NCT01175564** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** TC-5214
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01175564
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2013-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01175564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01175564, "To Investigate Safety, Tolerability and Pharmacokinetics of TC-5214 in Healthy Male Japanese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01175564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*